Progress in the development of small molecules as new human A3 adenosine receptor ligands based on the 3-thiophenylcoumarin core
Matos MJ., Vilar S., Kachler S., Vazquez-Rodriguez S., Varela C., Delogu G., Hripcsak G., Santana L., Uriarte E., Klotz K-N., Borges F.
3-Thiophenylcoumarins are described as adenosine receptor ligands. Synthesis, in vitro pharmacological assays and docking studies were performed.